Moonwalk Biosciences
Matthew Shin is a dedicated researcher with extensive experience in the fields of nanotechnology and polymer chemistry. Currently serving as a Graduate Student Researcher at the University of California San Diego, Matthew focuses on engineering plant-based, viral nanoparticle platforms for innovative healthcare solutions. Matthew's previous roles include a Technology Consultant at Grip Boost Inc., where a blend of research and marketing strategies are employed to foster business opportunities in the sports industry, and a Research Development Engineer at The Johns Hopkins University School of Medicine, specializing in pharmaceutical formulations for ophthalmology. Matthew holds a Ph.D. in NanoEngineering with a focus on Biomedical Nanotechnology from UC San Diego and a B.S. in Chemistry from the University of Maryland Baltimore County.
This person is not in any teams
Moonwalk Biosciences
Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineering. The combination enables both a novel discovery platform and a path to developing therapeutics that include both epigenetic engineering and other traditional modalities.